SIGA Technologies Inc
NASDAQ:SIGA
SIGA Technologies Inc
Revenue
SIGA Technologies Inc
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
SIGA Technologies Inc
NASDAQ:SIGA
|
Revenue
$138.7m
|
CAGR 3-Years
1%
|
CAGR 5-Years
39%
|
CAGR 10-Years
46%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Revenue
$88.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Revenue
$48.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
|
Pfizer Inc
NYSE:PFE
|
Revenue
$63.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Revenue
$64.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Revenue
$45B
|
CAGR 3-Years
17%
|
CAGR 5-Years
15%
|
CAGR 10-Years
9%
|
|
SIGA Technologies Inc
Glance View
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company is headquartered in New York City, New York and currently employs 39 full-time employees. The Company’s lead product, TPOXX (oral TPOXX), is an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The firm does not have a manufacturing infrastructure and does not intend to develop one for the manufacture of TPOXX. The company uses contract manufacturing organizations (CMOs) to procure commercial raw materials and supplies, and to manufacture TPOXX. The Company’s CMOs apply methods and controls in facilities, which are uses for manufacturing, processing, packaging, testing, analyzing and holding pharmaceuticals, which conform to current good manufacturing practices (cGMP), the standard set by the FDA for manufacture and storage of pharmaceuticals intended for human use. For the manufacture of oral TPOXX, the Company uses the four CMOs, namely W.R. Grace and Company; Powdersize, LLC; Catalent Pharma Solutions LLC, and Packaging Coordinators, LLC.
See Also
What is SIGA Technologies Inc's Revenue?
Revenue
138.7m
USD
Based on the financial report for Dec 31, 2024, SIGA Technologies Inc's Revenue amounts to 138.7m USD.
What is SIGA Technologies Inc's Revenue growth rate?
Revenue CAGR 10Y
46%
Over the last year, the Revenue growth was -1%. The average annual Revenue growth rates for SIGA Technologies Inc have been 1% over the past three years , 39% over the past five years , and 46% over the past ten years .
You don't have any saved screeners yet